Cargando…

Sodium-glucose co-transporter 2 (SGLT2) inhibitors: a growing class of antidiabetic agents

Although several treatment options are available to reduce hyperglycemia, only about half of individuals with diagnosed diabetes mellitus (DM) achieve recommended glycemic targets. New agents that reduce blood glucose concentrations by novel mechanisms and have acceptable safety profiles are needed...

Descripción completa

Detalles Bibliográficos
Autor principal: Vivian, Eva M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Just Medical Media Limited 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295914/
https://www.ncbi.nlm.nih.gov/pubmed/25598831
http://dx.doi.org/10.7573/dic.212264